Will the Minister of AYURVEDA, YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY (AYUSH) be pleased to state:
(a) whether the Government assessments indicate a three-fold increase in market size of ayurvedic products from $ 2.5 billion to $ 8 billion by the year 2022;
(b) if so, whether the Government has formulated any scheme for promotion/ development of AYUSH clusters across the country; and
(c) if so, the details thereof and the action taken by the Government in this regard?
ANSWER
THE MINISTER OF STATE (IC) OF THE MINISTRY OF AYURVEDA,
YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY
(SHRI SHRIPAD YESSO NAIK)
(a): Yes, estimates indicate approximately three-fold increase in the market size of Ayurveda products by 2022 at a compound annual growth rate of about 16.2%.
(b) & (c) Implementation of a ‘Central Sector Scheme for Development of AYUSH Industry Clusters” was initiated in the 11thFive Year Plan period for filling in the critical gaps related to standardization, quality assurance and control, productivity, marketing, infrastructure Certification and capacity building of AYUSH industry. Objective of the cluster based approach was to encourage the level of organization in the sector thereby by creating social capital for sustainability of collective initiatives by way of grant to the Special Purpose Vehicle (SPV) formed by group of entrepreneur from AYUSH sector. The scheme funded ten projects in different parts of the country till 31st March, 2017 and has been discontinued thereafter.
Department of Pharmaceuticals is also operating a Cluster Development Scheme for providing financial assistance to Special Purpose Vehicle (SPV) to develop common facilities. Minimum three members of SPV must be pharmaceutical manufacturers is the eligibility condition to avail the scheme. Subject to fulfillment of the prescribed conditions, AYUSH drug manufacturers can also avail the benefits of common facilities of the cluster.
………………